Activin A and follistatin in acute liver failure

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 2, 2003, Pages 127-131

  Hughes, Robin D ^a,b   Evans, Lee W ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Activin A; Acute liver failure; Follistatin; Liver regeneration; Transforming growth factor 1

Indexed keywords

ACTIVIN A; FOLLISTATIN; PARACETAMOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG OVERDOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; LIVER FAILURE; LIVER REGENERATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS;

ACETAMINOPHEN; ACTIVINS; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLISTATIN; HEPATITIS; HUMANS; INHIBIN-BETA SUBUNITS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0037331887     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200302000-00004     Document Type: Article

References (27)

1. Rakela J, Lange S, Ludwig J, Baldus W. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985; 60:289-292.
2. Miwa Y, Harrison PM, Farzaneh F, Langley PG, Williams R, Hughes RD. Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure. J Hepatol 1997; 27:780-788.
3. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993; 92:1491-1496.
4. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 1993; 18:347-356.
5. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillet NA. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 1994; 20:854-862.
6. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from ovary is follistafin. Science 1990; 247:836-838.
7. Michel U, Farnworth UM, Findlay JK. Follistatin: more than follistatin-stimulating hormone suppressing proteins. Mol Cell Endocrinol 1993; 91:1-11.
8. Zhang YQ, Kanzaki M, Shibata H, Kojima I. Regulation of the expression of follistatin in rat hepatocytes. Biochem Biophys Acta 1997; 1354:204-210.
9. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148:267-279.
10. Evans LW, Muttukrishna S, Groome NP. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. J Endocrinol 1998; 156:275-282.
11. Gressner AM, Lahme B, Mannherz HG, Polzar B. TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26:1079-1092.
12. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1988; 97:439-445.
13. Patella S, Phillips DJ, de Kretzer DM, Evans LW, Groome NP, Sievert W. Characterization of serum activin A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. J Hepatol 2001; 34:576-583.
14. Yuen M-F, Norris S, Evans LW, Langley PG, Hughes RD. Transforming growth factor-β1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis. Scand J Gastroenterol 2002; 34:233-238.
15. Shi Q, Gaylor JD, Cousins R, Plevris J, Hayes P, Grant MH. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998; 22:1023-1030.
16. Anderson C, Thabrew MI, Hughes RD. Assay to detect inhibitory substances in serum in acute liver failure. Int J Artif Organs 1999; 22:113-117.
17. Russell CE, Hedger MP, Brauman JN, de Kretser DM, Phillips DJ. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol 1999; 148:129-136.
18. Chen W, Woodruff TK, Mayo KE. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins. Endocrinology 2000; 141:1263-1272.
19. Yamada H, Hughes RD, Gove CD, Williams R. Effects of fulminant hepatic failure serum on hepatic DNA synthesis in normal and partially hepatectomised rats. Eur J Gastroenterol Hepatol 1990; 2:483-488.
20. Yamada H, Toda G, Yoshiba M, Hashimoto N, Ikeda Y, Mitsui H, et al. Humoral inhibitor of hepatocyte DNA synthesis from patients with fulminant hepatic failure. Hepatotogy 1994; 19:1133-1140.
21. Ichikawa T, Zhang YQ, Kogure K, Hasegawa Y, Takagi H, Mori M, et al. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 2001; 34:918-925.
22. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 1995; 108:1136-1142.
23. Michel U, Schneider O, Kirchof C, Meisel S, Smirnic A, Wiltfang J, et al. Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362. Endocrinology 1996; 137:4925-4934.
24. Phillips DJ, Jones KL, Scheerlinck J-PY, Hedger MP, de Kretzer DM. Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol 2001; 180:155-162.
25. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32:734-739.
26. Keane HM, Sheron N, Goka J, Hughes RD, Williams R. Plasma inhibitory activity against tumor necrosis factor in fulminant hepatic failure. Clin Sci 1996; 90:77-80.
27. Izumi S, Hughes RD, Langley PG, Pernambuco JRB, Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut 1994; 35:982-986.